| Date Filed | Type | Description |
| 08/14/2023 |
4
| Hasnain Faheem (Director) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Bought 10,791 shares
@ $27.8, valued at
$300k
|
|
| 07/26/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/02/2023 |
4
| Hasnain Faheem (Director) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 26,000 options to buy
@ $13.32, valued at
$346.3k
|
|
| 05/09/2023 |
4
| Hasnain Faheem (President & CEO) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Granted 750,000 options to buy
@ $1.36, valued at
$1M
|
|
| 03/22/2023 |
4
| Hasnain Faheem (President & CEO) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Bought 168,683 shares
@ $1.0344, valued at
$174.5k
Bought 269,389 shares
@ $1.1965, valued at
$322.3k
Bought 440,500 shares
@ $1.1432, valued at
$503.6k
Granted 544,500 options to buy
@ $1.21, valued at
$658.8k
|
|
| 01/24/2023 |
4
| Hasnain Faheem (Director) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 6,333 shares
@ $0
Granted 10,716 options to buy
@ $45.66, valued at
$489.3k
|
|
| 12/09/2022 |
4
| Hasnain Faheem (President & CEO) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Granted 544,500 options to buy
@ $2.16, valued at
$1.2M
|
|
| 07/15/2022 |
4
| Hasnain Faheem (President & CEO) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Bought 138,696 shares
@ $7.21, valued at
$1000k
|
|
| 06/23/2022 |
4
| Hasnain Faheem (Director) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 23,000 options to buy
@ $14.84, valued at
$341.3k
|
|
| 03/24/2022 |
4
| Hasnain Faheem (President & CEO) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Sold 19,035 shares
@ $8.915, valued at
$169.7k
|
|
| 01/18/2022 |
4
| Hasnain Faheem (Director) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 3,619 shares
@ $0
Granted 5,243 options to buy
@ $124.31, valued at
$651.8k
|
|
| 01/10/2022 |
4
| Hasnain Faheem (President & CEO) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Granted 650,000 options to buy
@ $11.94, valued at
$7.8M
|
|
| 06/23/2021 |
4
| Hasnain Faheem (Director) has filed a Form 4 on Kura Oncology, Inc.|
Txns:
| Granted 23,000 options to buy
@ $21.54, valued at
$495.4k
|
|
| 03/01/2021 |
4
| Hasnain Faheem (President & CEO) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Granted 162,500 shares
@ $0
Granted 325,000 options to buy
@ $9.79, valued at
$3.2M
|
|
| 02/26/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2021 |
SC 13G
| Gossamer Bio, Inc. reports a 4.6% stake in GOSSAMER BIO, INC. |
| 01/20/2021 |
4
| Hasnain Faheem (Director) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 2,098 shares
@ $0
Granted 3,064 options to buy
@ $214.47, valued at
$657.1k
|
|
| 10/14/2020 |
4
| Hasnain Faheem (Director) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Bought 96,520 shares
@ $10.3605, valued at
$1000k
|
|
| 06/30/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2020 |
4
| Hasnain Faheem (Director) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Granted 47,000 options to buy
@ $12.1, valued at
$568.7k
|
|
| 02/10/2020 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 01/07/2020 |
4
| Hasnain Faheem (Director) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 3,000 shares
@ $0
Granted 6,000 options to buy
@ $113.2, valued at
$679.2k
|
|
| 10/04/2019 |
4
| Hasnain Faheem (Director) has filed a Form 4 on Tocagen Inc|
Txns:
| Granted 7,500 options to buy
@ $0.6391, valued at
$4.8k
|
|
| 09/27/2019 |
4
| Hasnain Faheem (Director) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Bought 10,000 shares
@ $16.798, valued at
$168k
|
|
| 06/27/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2019 |
4
| Hasnain Faheem (Director) has filed a Form 4 on Tocagen Inc|
Txns:
| Bought 38,860 shares
@ $4.5912, valued at
$178.4k
Bought 3,890 shares
@ $5.299, valued at
$20.6k
Bought 250 shares
@ $5.1495, valued at
$1.3k
|
|
| 05/31/2019 |
4
| Hasnain Faheem (Director) has filed a Form 4 on Tocagen Inc|
Txns:
| Granted 20,000 options to buy
@ $4.22, valued at
$84.4k
|
|
| 03/26/2019 |
4
| Hasnain Faheem (Executive Chairman) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Granted 43,500 options to buy
@ $22.1, valued at
$961.4k
|
|
| 02/20/2019 |
4
| Hasnain Faheem (Director) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 47,000 options to buy
@ $72.62, valued at
$3.4M
|
|
| 02/20/2019 |
3
| Hasnain Faheem (Director) has filed a Form 3 on Mirati Therapeutics, Inc. |
| 02/12/2019 |
4
| Hasnain Faheem (Executive Chairman) has filed a Form 4 on Gossamer Bio, Inc.|
Txns:
| Converted 58,599 shares
@ $0
Converted 185,984 preferred shares
@ $0
Converted 77,719 preferred shares
@ $0 |
|
| 02/07/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/17/2018 |
4
| Hasnain Faheem (Director) has filed a Form 4 on VITAL THERAPIES INC|
Txns:
| Sold 59,200 shares
@ $0.4377, valued at
$25.9k
Sold 118,243 shares
@ $0.4378, valued at
$51.8k
|
|
|